VSEE HEALTH, INC. (VSEE): Nasdaq/NYSE listing notice — Digital Health Acquisition Corp. receives Nasdaq delisting notice for failure to meet $50M MVLS standard

VSEE HEALTH, INC.

Nasdaq Staff notified company on Sept 28, 2023 of delisting determination due to MVLS below $50M for 30 consecutive trading days.
Company had 180-day cure period ending Sept 27, 2023 but failed to regain compliance with MVLS Rule 5450(b)(2)(A).
Company intends to request a hearing by Oct 5, 2023 to stay suspension; securities may continue trading until panel decision.
Company may apply to transfer listing to Nasdaq Capital Market if it meets continued listing requirements there.
There is no assurance the hearing panel will grant a stay or that the transfer to NasdaqCM will be approved.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

VSEE HEALTH, INC. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: market value
Rules: 5450(b)(2)(A)

Exact text from the filing

d Warrants) (the “Securities”) because it has not regained compliance with the Market Value of Listed Securities (“MVLS”) Standard. The market value of the Company’s listed Securities was below the $50,000,000 minimum MVLS requirement for continued listing on Nasdaq Global under Nasdaq Listing Rule 5450(b)(2)(A) (the “MLVS Rule”) and had not been at least $50,000,000 for the proceeding 30 consecutive trading days. As previously reported by the Company on its Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on April 6, 2023, the Staff initially notified t

View on SEC.gov

Browse all listing & compliance notices →

VSEE HEALTH, INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-105369

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.